Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

An exploration of Latino smokers and the use of pharmaceutical aids.

Levinson AH, Borrayo EA, Espinoza P, Flores ET, Pérez-Stable EJ.

Am J Prev Med. 2006 Aug;31(2):167-71. Epub 2006 Jun 5.

PMID:
16829334
2.

Latinos report less use of pharmaceutical aids when trying to quit smoking.

Levinson AH, Pérez-Stable EJ, Espinoza P, Flores ET, Byers TE.

Am J Prev Med. 2004 Feb;26(2):105-11.

PMID:
14751320
3.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
4.
5.

Evaluation of smoking cessation behaviors and interventions among Latino smokers at low-income clinics in a US-Mexico border county.

Sias JJ, Urquidi UJ, Bristow ZM, Rodriguez JC, Ortiz M.

Addict Behav. 2008 Feb;33(2):373-80. Epub 2007 Oct 5.

PMID:
18006240
6.

Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?

Chatkin JM, Mariante de Abreu C, Haggsträm FM, Wagner MB, Fritscher CC.

Addiction. 2004 Jun;99(6):778-84.

PMID:
15139876
7.

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.

Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.

8.

Characteristics of selectors of nicotine replacement therapy.

Shiffman S, Di Marino ME, Sweeney CT.

Tob Control. 2005 Oct;14(5):346-55.

9.

Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.

Lutsenko H, Doran CM, Hall WD.

Drug Alcohol Rev. 2008 Mar;27(2):160-4. doi: 10.1080/09595230701829462.

PMID:
18264876
11.

Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance.

Shiffman S, Ferguson SG, Rohay J, Gitchell JG.

Addiction. 2008 Aug;103(8):1371-8. doi: 10.1111/j.1360-0443.2008.02268.x.

PMID:
18855827
12.

Predictive factors in smoking cessation with combined therapy with bupropion and nicotine patches.

Sampablo I, Lores L, Coll-Klein F, Jimenez C, Rebasa P.

Monaldi Arch Chest Dis. 2003 Apr-Jun;59(2):171-6.

PMID:
14635510
13.

Smoking cessation in pregnancy.

Rore C, Brace V, Danielian P, Williams D.

Expert Opin Drug Saf. 2008 Nov;7(6):727-37. doi: 10.1517/14740330802196756 . Review.

PMID:
18983219
14.

Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.

Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S.

Clin Drug Investig. 2009;29(10):655-65. doi: 10.2165/11317730-000000000-00000.

PMID:
19715382
15.
16.

Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation.

Lam TH, Abdullah AS, Chan SS, Hedley AJ; Hong Kong Council on Smoking and Health Smoking Cessation Health Centre (SCHC) Steering Group.

Psychopharmacology (Berl). 2005 Feb;177(4):400-8. Epub 2004 Jul 29.

PMID:
15289997
17.

Discontinuation of nicotine replacement therapy among smoking-cessation attempters.

Burns EK, Levinson AH.

Am J Prev Med. 2008 Mar;34(3):212-5. doi: 10.1016/j.amepre.2007.11.010.

PMID:
18312809
18.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
19.
20.
Items per page

Supplemental Content

Write to the Help Desk